Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Andreas Wirger"'
Autor:
med. Andreas Wirger, med. Thomas-Alexander Vögeli, med. Wolfgang Vilmar, Cajetan Nzeh, med. Björn Volkmer
Publikováno v:
Uro-News. 19:36-36
Warm oder kalt? Wer Rezidive bei Harnblasenkarzinomen vermeiden will, setzt am besten auf Warme: Die hypertherme Instillationschemotherapie liefert bisher sehr gute Ergebnisse. Der Behandlungserfolg hangt aber auch davon ab, wie die Warme entsteht.
Autor:
Frank G E, Perabo, Christian, Frössler, Gregor, Landwehrs, Doris H, Schmidt, Alexander, von Rücker, Andreas, Wirger, Stefan C, Müller
Publikováno v:
Anticancer research. 26(3A)
In traditional Chinese Medicine, the preparation Danggui Longhui Wan has been used for years in the treatment of chronic myelocytic leukemia. The compound indirubin has been shown to be the active constituent. A cell permeable derivative, indirubin-3
Autor:
Andreas, Wirger, Frank G E, Perabo, Susanne, Burgemeister, Ludwig, Haase, Doris H, Schmidt, Christian, Doehn, Stefan C, Mueller, Dieter, Jocham
Publikováno v:
Anticancer research. 25(6B)
Flavopiridol is a semi-synthetic flavone analog of the alkaloid, rohitukine, a compound from an Indian tree, Dysoxylum binectariferum. It has been shown to inhibit cyclin-dependent kinases (CDKs), causing cell cycle arrest and growth inhibition. Flav
Autor:
Frank G E, Perabo, Patricia L, Willert, Andreas, Wirger, Doris H, Schmidt, Alexander, Von Ruecker, Stefan C, Mueller
Publikováno v:
Anticancer research. 25(5)
Superantigens are among the most potent T-cell mitogens known. Since T-cell activation and T-cell-derived cytokines play a role in the immune response associated with intravesical Bacillus Calmette-Guerin (BCG) application, this study was initiated t
Autor:
Frank G E, Perabo, André W, Demant, Andreas, Wirger, Doris H, Schmidt, Mario, Sitia, Eva, Wardelmann, Stefan C, Müller, Elise C, Kohn
Publikováno v:
Anticancer research. 25(2A)
Carboxyamido-triazole (CAI) is an orally bioavailable calcium influx and signal transduction inhibitor that has been shown to be anti-invasive, anti-angiogenic and anti-metastatic in different human tumors including transitional cell carcinoma. This
Autor:
Alexander von Ruecker, Eva Wardelmann, Stefan C. Mueller, Frank G.E. Perabo, Doris Schmidt, Andreas Wirger, Mario Sitzia, Patricia L. Willert
Publikováno v:
International journal of cancer. 115(4)
Superantigens are potent activators of T lymphocytes; therefore, their characteristics can be exploited in diseases where immunomodulation is known to be effective. In this study, we evaluated a new approach for the intravesical therapy of superficia
Autor:
Frank G E, Perabo, Andreas, Wirger, Stefan, Kamp, Heike, Lindner, Doris H, Schmidt, Stefan C, Müller, Elise C, Kohn
Publikováno v:
Anticancer research. 24(5A)
Pro- and anti-apoptotic factors and intracellular signaling pathways are targets for therapeutic development of anticancer agents. Carboxyamido-triazole (CAI) is an inhibitor of transmembrane calcium influx and intracellular calcium-requiring signal
Autor:
Gabriel Steiner, Stefan Kamp, Alexander von Ruecker, Doris Schmidt, Roland Mattes, Frank G.E. Perabo, Stefan Müller, Andreas Wirger, Katrin Pegelow
Publikováno v:
Urologic oncology. 6(4)
Circulating soluble Fas (sFas) and expression of Fas-ligand on cancer cells are mechanisms of immune escape. The aim of the present study was to investigate expression and production of Fas and Fas-ligand on bladder cancer cell lines of different gra
Autor:
Gabriel Steiner, Frank G.E. Perabo, K Pegelow, Stefan Kamp, Stefan C. Mueller, Elise C. Kohn, Roland Mattes, Andreas Wirger, Peter Albers, Doris Schmidt, H Lindner, A. von Ruecker
Publikováno v:
British Journal of Cancer
Mechanisms of resistance against Fas-mediated cell killing have been reported in different malignancies. However, the biological response of immune escape mechanisms might depend on malignant transformation of cancer cells. In this study we investiga
862 Evaluation of a superantigen- mediated immune response as therapy for superficial bladder cancer
Autor:
Frank G.E. Perabo, A. Von Rücker, Peter Albers, P.L. Willert, E. Wardelmann, Doris Schmidt, S.C. Müller, M. Sitzia, Andreas Wirger
Publikováno v:
European Journal of Cancer Supplements. 1:S259